CVS Health

HQ
Woonsocket, Rhode Island, USA
Total Offices: 7
119,959 Total Employees
Year Founded: 1963

Similar Companies Hiring

Consumer Web • eCommerce • Information Technology • Retail • Software • Analytics • App development
3 Offices
300000 Employees
AdTech • eCommerce • Food • Marketing Tech • Retail
7 Offices
10000 Employees

CVS Health Company Stability & Growth

Updated on October 14, 2025

This page was generated by Built In using publicly available information and AI-based analysis of common questions about the company. It has not been reviewed or approved by the company.

What's the stability & growth outlook for CVS Health?

Strengths in revenue momentum, scale, and integrated market presence are accompanied by margin pressure, PBM and retail pricing challenges, and continued reliance on restructuring to offset headwinds. Together, these dynamics suggest a resilient top line and strategic positioning, with near‑term profitability and execution risks as the portfolio expands and the footprint is optimized.
Positive Themes About CVS Health
  • Strong Revenue Growth: Revenue has risen across recent years, with quarterly and trailing results showing year-over-year increases and management raising full‑year guidance. Growth is evident across major segments including pharmacy, health services, and insurance.
  • Strong Market Position & Advantage: The company operates at national scale across retail pharmacy, PBM, and insurance, with leadership in prescription revenue and a broad U.S. store and clinic footprint. Its integrated model and acquisitions (Aetna, Oak Street Health, Signify Health) reinforce competitive advantages.
  • Market Expansion: Expansion plans include adding community pharmacy locations, integrating acquired sites, and scaling primary care clinics alongside pharmacies. These moves extend reach in underserved areas and deepen the integrated care footprint.
Considerations About CVS Health
  • Declining Profitability: Net income and operating income declined in the prior year and GAAP earnings were pressured by litigation charges. Margin headwinds from pharmacy reimbursement and elevated medical costs continue to weigh on results.
  • Weak Market Position & Pricing Challenges: PBM share slipped following a large client loss and sector pricing pressure, and retail pharmacy economics remain pressured despite higher script volumes. The company competes in concentrated markets with intense pricing dynamics and scrutiny.
  • Overreliance on Cost-Cutting: Corporate layoffs, footprint rationalization, and store closures are ongoing parts of a multi‑year cost‑reduction program. Portfolio exits and restructuring actions accompany growth initiatives to stabilize earnings.
NEW
What does AI tell candidates about your employer brand?
Get your free AI reputation report today.
See AI Report
AI Report
AI Report

The insights on this page are generated by submitting structured prompts to some of the most popular large language models (“LLMs”) and summarizing recurring themes from the responses. Because the insights are generated using AI, they may contain errors. The insights do not necessarily reflect internal data, employee interviews, or verified company information. They may be influenced by incomplete, outdated, or inaccurate data, and may vary across LLM providers. These insights are intended for informational purposes only and should not be interpreted as a factual or definitive assessment of a company's reputation. Built In makes no representations or warranties regarding the accuracy, completeness, or reliability of this information, and disclaims any liability for any actions taken based on this information. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.
Is This Your Company? Claim Profile